12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

Imrie, K., Dicke, K.A., and Keating, A. Autologous bone marrow transplantation for acute myeloid leukemia.
Stem Cells, 14: 69-78, 1996.
Rowe, J.M. and Liesveld, J.L. Treatment and prognostic factors in acute myeloid leukaemia.
Baillieres.Clin.Haematol., 9: 87-105, 1996.
Kemoterapi
Bloomfield, C.D., Herzig, G.P., Peterson, B.A., and Wolff, S.N. Long-term survival of patients with acute myeloid
leukemia: updated results from two trials evaluating postinduction chemotherapy. Cancer, 80: 2186-2190, 1997.
Bloomfield, C.D., Shuma, C., Regal, L., Philip, P.P., Hossfeld, D.K., Hagemeijer, A.M., Garson, O.M., Peterson,
B.A., Sakurai, M., Alimena, G., Berger, R., Rowley, J.D., Ruutu, T., Mitelman, F., Dewald, G.W., and Swansbury,
J. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International
Workshop on Chromosomes in Leukemia. Cancer, 80: 2191-2198, 1997.
Mrozek, K., Heinonen, K., de-la-Chapelle, A., and Bloomfield, C.D. Clinical significance of cytogenetics in acute
myeloid leukemia. Semin.Oncol., 24: 17-31, 1997.
Schoch C, Haferlach T, Haase D, Fonatsch C, Loffler H, Schlegelberger B, Staib P, Sauerland MC, Heinecke A,
Buchner T, Hiddemann W. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations
show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol. 2001 Jan;112(1):118-
26.
Autolog KMT
Gorin, N.C., Labopin, M., Meloni, G., Korbling, M., Carella, A., Herve, P., Burnett, A., Rizzoli, V., Alessandrino,
E.P., Bjorkstrand, B., and et, a. Autologous bone marrow transplantation for acute myeloblastic leukemia in
Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone
Marrow Transplantation (EBMT). Leukemia, 5: 896-904, 1991.
Linker, C.A., Ries, C.A., Damon, L.E., Rugo, H.S., and Wolf, J.L. Autologous bone marrow transplantation for
acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the
busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transplant, 22: 865-872, 1998.
Mehta, J., Powles, R., Singhal, S., Horton, C., Tait, D., Milan, S., Meller, S., Pinkerton, C.R., and Treleaven, J.
Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable
prognostic factors. Bone Marrow Transplant., 16: 499-506, 1995.
Stuart, R.K. Autologous bone marrow transplantation for leukemia. Semin.Oncol., 20: 40-54, 1993 .
Allogen KMT
30